NEWS: Medidata Launches myMedidata LIVE: Patient-Facing Video Visit Capability Built Directly into the Rave EDC Platform
myMedidata provides patients with virtual access to all of their study needs in a single web application
Developed with Medidata’s Patient Insights group to improve the overall patient experience, myMedidata provides a suite of virtualized research technologies built on the life science industry’s most used data engine – Rave EDC (electronic data capture)
eConsent and eCOA (clinical outcomes assessment) also added to this newest myMedidata release
NEW YORK, October 14, 2020 -- Medidata, a Dassault Systèmes Company, the global leader in creating end-to-end solutions supporting the entire clinical trial process today announced the availability of myMedidata LIVE, a new feature on the myMedidata patient portal. myMedidata LIVE is a web-based, live video conferencing capability connecting patients virtually with their clinical trial study staff. Built on the industry’s leading Rave EDC (electronic data capture) platform already in use at more clinical research sites globally than any other system, myMedidata LIVE gives researchers and patients a way to engage in remote site visits within the platform of site and patient-facing technologies they are already using on the study.
myMedidata is Medidata’s newly released patient portal solution that provides patients with virtual access to all of their study needs in a single web application. It is built using responsive design principles -- as well as input from Medidata’s Patient Insights team, a group of patients and patient advocates -- and made to be accessible from any device with an internet connection. Particularly relevant during the current COVID-19 pandemic when in-person visits might be restricted, myMedidata LIVE video visits between patients and sites can replace scheduled site-based appointments and allow the study team to complete its data entry in Rave while the patients remain engaged offsite through myMedidata.
"The COVID-19 global pandemic represents a pivotal moment for virtual care as healthcare organizations seek ways to triage COVID-19 patients while minimizing exposure between patients and clinicians and continue to see patients fearful of catching COVID-19 if they visit the hospital or their physician's office," said Lynne A. Dunbrack, group vice president, IDC Health Insights.*
“myMedidata LIVE brings a meaningful capability to the clinical research community as virtualization technologies take on an increasingly important role,” said Anthony Costello, senior vice president of mHealth at Medidata. “As part of our myMedidata patient portal, patients and sites can rely on myMedidata LIVE as an alternative way to engage when in-person site visits are challenging or impossible.”
The latest version of myMedidata also includes two other important clinical tools, which have been redesigned for virtual use and can now be used through the web with a patient’s myMedidata account: myMedidata eConsent and myMedidata eCOA (clinical outcomes assessment). Both tools give sites the ability to maintain a consistent and traceable process, since they are directly integrated with Rave EDC, and use the same advanced, trusted technology previously accessed through the eConsent and eCOA apps. In addition, myMedidata eConsent now provides patients the opportunity to learn about and consent to clinical trials at home or at a remote location, and myMedidata eCOA easily and accurately captures patient outcomes.
Medidata is a wholly owned subsidiary of Dassault Systèmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.
*IDC PlanScape: Virtual Care," US44610619. May 2020
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.comand follow us @Medidata, The Operating System for Life SciencesTM.
Medidata, Rave, and myMedidata are registered trademarks of Medidata Solutions, Inc., a wholly owned subsidiary of Dassault Systèmes.
About Dassault Systèmes
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating ‘virtual experience twins’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes’ 20,000 employees are bringing value to more than 270,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com
Original News Publication - Dassault Systemes Newsroom